NCT01281059View on ClinicalTrials.gov

Prediction of Severity of Liver Disease Non Alcoholic Fatty Liver Disease in Patients With Suspected NAFLD by a 13C Octanoate Breath Test

NAUnknownINTERVENTIONAL
Timeline

Start Date

January 31, 2011

Conditions
NAFLD
Interventions
DEVICE

BreathID - Breath Test - 13C Octanoate

Trial Locations (1)

Unknown

Hadassah Medical Organization, Jerusalem

Sponsors

Collaborators (1)

Meridian Bioscience, Inc.
All Listed Sponsors
collaborator

Meridian Bioscience, Inc.

INDUSTRY

lead

Hadassah Medical Organization

OTHER